✦ LIBER ✦

Results of the phase I-II study of gemcitabine (GEM) in combination with oxaliplatin (OX) in patients (pts) with advanced non-small-cell lung cancer (NSCLC)

✍ Scribed by Faivre, S; Monnerat, C; Raymond, E; Taieb, J; Adi Vago, N; Vicente-Azevedo, J; Roux, N; kayitalire, L; Armand, J.P; Le Chevalier, T

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I–II and pharmacokinetic study com

✍ S. Faivre; E. Raymond; F. Lokiec; C. Monnerat; S. Novello; P. Pautier; C. Lhommé 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 164 KB

The combination of gemcitabine and oxali

✍ V. Franciosi; R. Barbieri; G. Vasini; E. Aitini; C. Cacciani; R. Capra; F. Greco 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 182 KB

A phase I–II study of docetaxel (D) and

✍ Quantin, X; Rebattu, P; Pujol, J; Morere, J; Azarian, M.R; Khial, F; Dumortier, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Gemcitabine plus oxaliplatin combination

✍ Kakolyris, Stylianos; Ziras, Nikolaos; Vamvakas, Lambros; Varthalitis, John; Pap 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Second-line treatment with single-agent

✍ van Putten, J.W.G; Baas, P; Codrington, H; Kwa, H.B; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Phase II study of oxaliplatin (L-OHP) in

✍ Monnet, I.; Brienza, S.; Voisin, S.; Gastiaburu, J.; Armand, J.P.; Cvitkovic, E. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 170 KB